List of works by Sarah A Best

"Keaping" a lid on lung cancer: the Keap1-Nrf2 pathway

scientific article published on 01 August 2018

A pooled shRNA screen for regulators of primary mammary stem and progenitor cells identifies roles for Asap1 and Prox1.

scientific article

Activated Notch counteracts Ikaros tumor suppression in mouse and human T-cell acute lymphoblastic leukemia

scientific article published on 6 February 2015

CCAR2 Is Required for Proliferation and Tumor Maintenance in Human Squamous Cell Carcinoma

scientific article published on 07 October 2016

Characterization of a novel human BFL-1-specific monoclonal antibody

scientific article published on 12 November 2019

Combining Cell Type-Restricted Adenoviral Targeting with Immunostaining and Flow Cytometry to Identify Cells-of-Origin of Lung Cancer.

scientific article published in January 2018

Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesis

scientific article published on 20 October 2020

Distinct initiating events underpin the immune and metabolic heterogeneity of KRAS-mutant lung adenocarcinoma

scientific article published on 13 September 2019

Dual roles for Id4 in the regulation of estrogen signaling in the mammary gland and ovary.

scientific article published on 18 July 2014

EGF-mediated induction of Mcl-1 at the switch to lactation is essential for alveolar cell survival

scientific article

FGFR3-TACC3 is an oncogenic fusion protein in respiratory epithelium

scientific article published on 10 July 2018

Lung morphogenesis is orchestrated through Grainyhead-like 2 (Grhl2) transcriptional programs

scientific article published on 05 September 2018

Pax5 loss imposes a reversible differentiation block in B-progenitor acute lymphoblastic leukemia

scientific article

Pro-apoptotic Bim suppresses breast tumor cell metastasis and is a target gene of SNAI2

article

Runx2 is a novel regulator of mammary epithelial cell fate in development and breast cancer

scientific article

Synergy between the KEAP1/NRF2 and PI3K Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment.

scientific article published on 2 March 2018